Home » Authors » Glen Harris

Glen Harris

Articles

ARTICLES

Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

No Abstract

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

No Abstract

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

No Abstract

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

No Abstract

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

No Abstract

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

View All Articles by Glen Harris

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...